ABOUT US
Based in New York City, Lexeo is a clinical stage company dedicated to applying pioneering science to fundamentally change how genetic cardiovascular and neurological diseases are treated.
By taking aim at the underlying genetic cause of the devastating diseases we target, we seek to create substantial positive impact and reduce the overwhelming burdens placed on people receiving treatment, their caregivers, and healthcare systems.
Le MISSION
Our mission is to transform healthcare by pushing boundaries in developing meaningful medicines for genetic diseases, regardless of prevalence.
Our vision is a world where transformative medicines resolve the burden of genetic disease, transforming all aspects of society.
xeo VISION
